Menu
The Goodman Institute Health Blog
  • Home
  • Authors
    • Devon Herrick, Ph.D.
    • John C. Goodman
  • Popular Topics
    • Affordable Care Act
    • Consumer-Driven Health Care
      • Cost of Healthcare
      • COVID-19 and Public Health
      • Doctors & Hospitals
      • Public Insurance
      • Policy & Legislation
    • Direct Primary Care
    • Drug Prices & Regulations
    • Health Economics & Costs
    • Health Insurance
    • Health Reform
    • Medical Tourism
    • Medicare
    • Single-Payer/Medicare-for-All
    • Telemedicine
  • Goodman Institute
  • Contact
The Goodman Institute Health Blog

Category: Policy & Legislation

Health Plans Now Required to Post Prices. Will it Help?

Posted on July 1, 2022 by Devon Herrick

An article in Kaiser Health News explained that health plans are now required to post the prices they have negotiated with all in-network health care providers. Failing to do so will result in substantial fines. The new rule is the result of an executive order then President Trump issued back in 2019.

Price transparency is the holy grail in health policy. There is not one price, but many prices depending on who the payer is. There is the list price that nobody pays unless uninsured and caught off-guard. There’s the cash price paid after receiving care. It is often same as the list price. Then there is the (lower) negotiated cash price if uninsured and paid in advance of receiving care. Then there are the prices Medicare pays and Medicaid pays. Health insurers may all have different prices for the same procedures. Indeed, prices vary tremendously across facilities. A knee replacement may be $30,000 at one hospital and $130,000 at another.

+

Friday Links

Posted on July 1, 2022July 25, 2022 by John C. Goodman
  • Healthier is wealthier: “We find that the intervention [to prevent heart disease] significantly increased earnings by 3 percent and family income by 4 percent with no concurrent effect on labor force participation.”
  • Can Public Choice explain why health care has been relatively unaffected by inflation?  Speculative.
  • Your health data might be for sale.
  • After learning that McKinsey urged Purdue to “turbocharge” sales of OxyContin (widely blamed for the opioid crisis), we now learn that it has been urging Endo to aggressively market a painkiller that is twice as potent.
  • NY Health Department advises users to consume fentanyl “safely.”
+

Tuesday Links

Posted on July 1, 2022July 25, 2022 by John C. Goodman
  • 1 in 5 adults say they have received an unexpected medical bill this year, even though surprise billing has been illegal since January.
  • Pregnant woman ticketed for driving alone in an HOV lane claims her fetus was the second passenger.
  • Two more studies find that giving people money doesn’t work: “getting the money reminded recipients that they were poor, without doing much to change that long-term condition, which in turn led to worse psychological health and lower happiness among recipients.”
  • Arnold Kling on the studies: “There are even worse results than that. It turns out that getting a windfall and ending up back where you started makes you feel worse than you did before getting the windfall.”
  • Did the Black Plague have beneficial economic effects? Tyler Cowen reviews James Belich’s The World the Plague Made.
  • Circadian medicine: “There’s a skin clock and a liver clock and an immune system clock; there’s a clock for the kidney, heart, lungs, muscles and reproductive system.”
+

Medicare Advantage: Lawmakers Say it’s Pretty Good but Could be Improved

Posted on June 30, 2022 by Devon Herrick

Energy and Commerce subcommittee on oversight and investigations met on Tuesday to beat up on Medicare Advantage plans. Chairwoman Rep. Diana DeGette (D-CO) claimed seniors are “required to jump through numerous hoops” to get the care they need.

+
  • Previous
  • 1
  • …
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • …
  • 70
  • Next

For many years, our health care blog was the only free enterprise health policy blog on the internet. Then, when the NCPA closed its doors, the health blog stopped as well.

During this five-year hiatus no one else has come forward to claim the space. So, my colleagues and I have decided to restart the blog in connection with the Goodman Institute. We invite you and others to use this forum to share your views.

John C. Goodman,

Visit www.goodmaninstitute.org

Subscribe via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 12 other subscribers

Popular Topics

©2023 The Goodman Institute Health Blog | Website by Lexicom